» Articles » PMID: 35861639

Behavioral Impulsivity is Associated with Pupillary Alterations and Hyperactivity in CDKL5 Mutant Mice

Overview
Journal Hum Mol Genet
Date 2022 Jul 21
PMID 35861639
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclin-dependent kinase-like 5 (Cdkl5) deficiency disorder (CDD) is a severe neurodevelopmental condition caused by mutations in the X-linked Cdkl5 gene. CDD is characterized by early-onset seizures in the first month of life, intellectual disability, motor and social impairment. No effective treatment is currently available and medical management is only symptomatic and supportive. Recently, mouse models of Cdkl5 disorder have demonstrated that mice lacking Cdkl5 exhibit autism-like phenotypes, hyperactivity and dysregulations of the arousal system, suggesting the possibility to use these features as translational biomarkers. In this study, we tested Cdkl5 male and female mutant mice in an appetitive operant conditioning chamber to assess cognitive and motor abilities, and performed pupillometry to assess the integrity of the arousal system. Then, we evaluated the performance of artificial intelligence models to classify the genotype of the animals from the behavioral and physiological phenotype. The behavioral results show that CDD mice display impulsivity, together with low levels of cognitive flexibility and perseverative behaviors. We assessed arousal levels by simultaneously recording pupil size and locomotor activity. Pupillometry reveals in CDD mice a smaller pupil size and an impaired response to unexpected stimuli associated with hyperlocomotion, demonstrating a global defect in arousal modulation. Finally, machine learning reveals that both behavioral and pupillometry parameters can be considered good predictors of CDD. Since early diagnosis is essential to evaluate treatment outcomes and pupillary measures can be performed easily, we proposed the monitoring of pupil size as a promising biomarker for CDD.

Citing Articles

Independent genetic strategies define the scope and limits of CDKL5 deficiency disorder reversal.

Song X, Xia Z, Martinez D, Xu B, Spritzer Z, Zhang Y Cell Rep Med. 2025; 6(2):101926.

PMID: 39855191 PMC: 11866500. DOI: 10.1016/j.xcrm.2024.101926.


A comparative machine learning study of schizophrenia biomarkers derived from functional connectivity.

Shevchenko V, Benn R, Scholz R, Wei W, Pallavicini C, Klatzmann U Sci Rep. 2025; 15(1):2849.

PMID: 39843572 PMC: 11754439. DOI: 10.1038/s41598-024-84152-2.


A Survey on AI-Driven Mouse Behavior Analysis Applications and Solutions.

Guo C, Chen Y, Ma C, Hao S, Song J Bioengineering (Basel). 2024; 11(11).

PMID: 39593781 PMC: 11591614. DOI: 10.3390/bioengineering11111121.


Epilepsy-linked kinase CDKL5 phosphorylates voltage-gated calcium channel Cav2.3, altering inactivation kinetics and neuronal excitability.

Sampedro-Castaneda M, Baltussen L, Lopes A, Qiu Y, Sirvio L, Mihaylov S Nat Commun. 2023; 14(1):7830.

PMID: 38081835 PMC: 10713615. DOI: 10.1038/s41467-023-43475-w.


Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.

Mottolese N, Uguagliati B, Tassinari M, Cerchier C, Loi M, Candini G Biomolecules. 2023; 13(9).

PMID: 37759796 PMC: 10527551. DOI: 10.3390/biom13091396.